Skip to main navigation Skip to search Skip to main content

WSRF-based modeling of clinical trial information for collaborative cancer research

  • Tianyi Zang*
  • , Radu Calinescu
  • , Steve Harris
  • , Andrew Tsui
  • , Marta Kwiatkowska
  • , Jeremy Gibbons
  • , Jim Davies
  • , Peter Maccallum
  • , Carlos Caldas
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

5 Scopus citations

Abstract

The CancerGrid consortium is developing open-standards cancer informatics to address the challenges posed by modern cancer clinical trials. This paper presents the service-oriented software paradigm implemented in CancerGrid to derive clinical trial information management systems for collaborative cancer research across multiple institutions. Our proposal is founded on a combination of a clinical trial (meta)model and WSRF (Web Services Resource Framework), and is currently being evaluated for use in early phase trials. Although primarily targeted at cancer research, our approach is readily applicable to other areas for which a similar information model is available.

Original languageEnglish
Title of host publicationProceedings CCGRID 2008 - 8th IEEE International Symposium on Cluster Computing and the Grid
Pages73-81
Number of pages9
DOIs
StatePublished - 2008
Externally publishedYes
EventCCGRID 2008 - 8th IEEE International Symposium on Cluster Computing and the Grid - Lyon, France
Duration: 19 May 200822 May 2008

Publication series

NameProceedings CCGRID 2008 - 8th IEEE International Symposium on Cluster Computing and the Grid

Conference

ConferenceCCGRID 2008 - 8th IEEE International Symposium on Cluster Computing and the Grid
Country/TerritoryFrance
CityLyon
Period19/05/0822/05/08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'WSRF-based modeling of clinical trial information for collaborative cancer research'. Together they form a unique fingerprint.

Cite this